The global cell culture market is estimated to value over USD 25.4 billion and register a CAGR of over 10.8%from the forecast period 2019 to 2026. The rising demand for bioproduction has led to manufacturers aiming at commercialization and development of many biopharmaceutical products such as therapeutic, monoclonal antibody and vaccines is driving the market.
Cell Culture Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026 The global cell culture market is estimated to value over USD 25.4 billion and register a CAGR of over 10.8%from the forecast period 2019 to 2026. The rising demand for bioproduction has led to manufacturers aiming at commercialization and development of many biopharmaceutical products such as therapeutic, monoclonal antibody and vaccines is driving the market. Increasing preference for single-use technologies and increasing funds for cell-based research is accelerating the market growth. The rise in R&D activity is further expected to spur the market. The market is classified into by product, application, type, end-user, and region. Based on type, the cell structure is segmented into sera, media & reagents, vessels and bioreactor accessories. Sera, media & reagents are expected to hold a vast share of the market. The rise in the purchase of sera, media, and reagents for multiple biopharmaceutical production, toxicology and vaccine production is boosting the market. Serum-free media eliminates the risk of contamination by viruses. Sera, media, and reagents are an integral part of experiments related to cells as they provide enhanced results. In terms of application, biopharmaceutical production is expected to hold a major share of the market. The expansion of prominent pharmaceutical companies and increasing regulatory permissions for production of vaccines based on cell culture remains the key factor responsible for the market escalation. Rising demand for monoclonal antibodies is also fueling the growth of the market. Based on end-users, pharmaceutical and biotechnology companies are expected to showcase exponential growth owing to increasing demand for single-use technologies and growing government approvals towards cell culture-based vaccines. The presence of an ample number of pharmaceutical players is also positively influencing the market. In terms of regions, North America is the global leader of the market. Government and private enterprises rising interest in vaccines related to cell culture and higher investments in cell-based research are driving the growth of the market in the region. Growing prevalence regarding the latest trends in cell culture technology and rapid expansion of pharmaceutical industries is bolstering the market. Asia-Pacific region is also expected to show significant growth due to strong support from the governments of Japan, China, and India. The strategic developments made by prominent players are expected to boost the presence of the market in Japan. The increasing initiative by the Indian government to promote life science industry is escalating the market in the region. Prominent players of the market are Lonza, Becton, Dickinson, and Company, Merck KGaA, Corning Incorporated, CellGenix GmbH, Eppendorf AG, PromoCell GmbH, GE Healthcare, HiMedia Laboratories, Sartorius AG, InvivoGen and Irvine Scientific. Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=3357&page=requestsample Competitive Landscape: ● Thermo Fisher Scientific in 2019 invested USD 150 million to expand its capacity of lyophilized product development and sterile liquids. Their centres across Italy and the US will have aseptic filling lines alongside isolator technology which will help in strengthening the company's customer base worldwide ● Merck in 2018 opened its BioReliance biosafety testing lab in Singapore. Their new lab will offer critical testing services which would further augment the market FutureWise Key Takeaways ● According to our industry experts, single-use bioreactors are expected to witness immense demand owing to the rising adoption of single-use technologies. Single-use technologies offer benefits such as low price and low contamination risk. In addition, the demand for mAbs is also fueling the demand of single-use bioreactors thus propelling the market ● Europe is expected to be a high growth profit region owing to the growing support of private investors and the government for R&D activity in countries like Germany and France. Expansion of the life science industry in the UK is also positively influencing the market Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=3357&page=askfordiscount Global Cell Culture Market Segmentation By Product ● Consumables ▪ Sera, Media and Reagents ▪ Vessels ▪ Bioreactor Accessories ● Equipment ▪ Supporting Equipment ▪ Bioreactors ▪ Storage Equipment By Application ● Biopharmaceutical Production ● Diagnostics ● Drug Screening and Development ● Stem Cell Research ● Tissue Engineering & Regenerative Medicine By End-User ● Pharmaceutical & Biotechnology Companies ● Hospitals and Diagnostic Laboratories ● Research Institutes By Region ● North America ● Europe ● Asia Pacific ● Latin America ● Rest of the World Objectives of the Study: • To provide with an exhaustive analysis on the global cell culture market by product, by application, by end-user, and by region • To cater to comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers, and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies Table of Contents 1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Years Considered for the Study 1.4 Currency 1.5 Limitation 1.6 Stakeholders 2 Research Methodology 2.1 Research Data 2.2 Secondary Data 2.2.1 Secondary Source 2.3 Primary Data 2.3.1 Key Data From Primary Sources 2.4 Market Size Estimation 2.5 Market Breakdown and Data Triangulation 2.6 Assumptions for the Study 3 Executive Summary 4 Premium Insights 4.1 Cell Culture: Market Overview 4.2 Asia Pacific: Cell Culture Market Share, By End User and Country (2019) 4.3 Cell Culture Sera, Media, & Reagents Market, By Type (USD Billion) 4.4 Cell Culture Market, By Application, 2019 vs 2026 (USD Billion) 4.5 Cell Culture Market, By Product, 2019 vs 2026 (USD Billion) 4.6 Geographical Snapshot of the Cell Culture Market 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Market Drivers 188.8.131.52 Growing Awareness About the Benefits of Cell Culture-Based Vaccines 184.108.40.206 Increasing Demand for Monoclonal Antibodies 220.127.116.11 Funding for Cell-Based Research 18.104.22.168 Growing Preference for Single-Use Technologies 22.214.171.124 Launch of Advanced Cell Culture Products 126.96.36.199 Growing Focus on Personalized Medicine 5.2.2 Market Restraints 188.8.131.52 High Cost of Cell Biology Research 184.108.40.206 Lack of Infrastructure for Cell-Based Research in Emerging Economies 5.2.3 Market Opportunities 220.127.116.11 Growing Demand for 3D Cell Culture 18.104.22.168 Increased Risk of Pandemics and Communicable Diseases 22.214.171.124 Emerging Economies 6 Cell Culture Market, By Product 6.1 Introduction 6.2 Consumables 6.2.1 Sera, Media, and Reagents 126.96.36.199 Media 188.8.131.52.1 Serum-Free Media 184.108.40.206.1.1 Lack of Sera Eliminates the Risk of Contamination By Viruses 220.127.116.11.2 Classical Media & Salts 18.104.22.168.2.1 Classical Media is Commonly Used in Diagnostics and Manufacturing 22.214.171.124.3 Stem Cell Culture Media 126.96.36.199.3.1 Stem Cell Culture Media Will Witness the Highest Growth in the APAC Market 188.8.131.52.4 Specialty Media 184.108.40.206.4.1 Specialty Media is Suitable for Specific, Selective Cell Types 220.127.116.11 Reagents 18.104.22.168.1 Supplements & Growth Factors 22.214.171.124.1.1 Supplements Such as Amino Acids Play A Key Role in Inducing Cell Growth 126.96.36.199.2 Buffers & Chemicals 188.8.131.52.2.1 Chemical Buffers are Widely Used, But are Expensive and Can Be Toxic 184.108.40.206.3 Cell Dissociation Reagents 220.127.116.11.3.1 Dissociation Reagents Can Be Enzymatic Or NonEnzymatic 18.104.22.168.4 Balanced Salt Solutions 22.214.171.124.4.1 Salt Solutions Find Wide Applications in Life Sciences 126.96.36.199.5 Attachment & Matrix Factors 188.8.131.52.5.1 Development of Cells is Dependent on Attachment Factors 184.108.40.206.6 Antibiotics/Antimycotics 220.127.116.11.6.1 Possibility of Toxicity and Contamination Risks Make Long-Term Use of Antibiotics/Antimycotics Conditional 18.104.22.168.7 Contamination Detection Kits 22.214.171.124.7.1 Kits Provide Results in Hours, Much Faster Than Direct Culture Methods 126.96.36.199.8 Cryoprotective Reagents 188.8.131.52.8.1 Inorganic Expansions are A Favored Strategy for Companies in This Market 184.108.40.206.9 Other Cell Culture Reagents 220.127.116.11 Sera 18.104.22.168.1 Fetal Bovine Sera 22.214.171.124.1.1 Use of Fbs is Associated With Ethical Issues 126.96.36.199.2 Adult Bovine Sera 188.8.131.52.2.1 ABS is Used as A Biochemical Agent in Ivd 184.108.40.206.3 Other Animal Sera 6.2.2 Vessels 220.127.116.11 Roller/Roux Bottles 18.104.22.168.1 Roller Bottles Offer an Economical Means of Cultivating Large Cell Volumes 22.214.171.124 Cell Factory Systems/Cell Stacks 126.96.36.199.1 Cell Stacks Require Special Handling Equipment and Skilled Expertise 188.8.131.52 Multiwell Plates 184.108.40.206.1 Larger Well Formats Allow for Greater Culture Volumes 220.127.116.11 Flasks 18.104.22.168.1 Disposable Flasks are in Greater Demand Among End Users 22.214.171.124 Petri Dishes 126.96.36.199.1 Wide Usage of Petri Dishes is Attributed to Their Ease of Use 6.2.3 Bioreactor Accessories 6.3 Equipment 6.3.1 Supporting Equipment 188.8.131.52 Filtration Systems 184.108.40.206.1 Growing Research in Cell Biology is A Key Factor Driving Market Growth 220.127.116.11 Cell Counters 18.104.22.168.1 Automated Cell Counters are Witnessing Growing Demand 22.214.171.124 Carbon Dioxide Incubators 126.96.36.199.1 Incubators Provide Control Over Atmospheric Conditions for Best Effect 188.8.131.52 Centrifuges 184.108.40.206.1 Technological Advances have Enabled the Development of Faster, More Effective Centrifuges 220.127.116.11 Autoclaves 18.104.22.168.1 Autoclaves Sterilize Equipment and Supplies for Use 22.214.171.124 Microscopes 126.96.36.199.1 Inverted Microscopes are Widely Used in Cell Culture Processes 188.8.131.52 Biosafety Cabinets 184.108.40.206.1 Cabinets are Classified Into Three Classes Based on Protection Offered 220.127.116.11 Other Supporting Equipment 6.3.2 Bioreactors 18.104.22.168 Conventional Bioreactors 22.214.171.124.1 Conventional Bioreactors Hold the Largest Share of the Bioreactors Market 126.96.36.199 Single-Use Bioreactors 188.8.131.52.1 Convenience, Ease of Use, and Flexibility are Driving Demand for Single-Use Bioreactors 6.3.3 Storage Equipment 184.108.40.206 Refrigerators & Freezers 220.127.116.11.1 Refrigerators & Freezers are Used for Both Short and Long-Term Storage 18.104.22.168 Cryostorage Systems 22.214.171.124.1 Benefits of Long-Term Preservation of Cell Cultures are Driving Market Growth 7 Cell Culture Market, By Application 7.1 Introduction 7.2 Biopharmaceutical Production 7.2.1 Therapeutic Proteins 126.96.36.199 Growing Applications of Recombinant Proteins to Drive This Segment 7.2.2 Vaccine Production 188.8.131.52 Rising Incidence of Disease Outbreaks to Drive the Market for Vaccine Production 7.3 Diagnostics 7.3.1 Cell Cultures are Used in the Diagnosis of Viral Diseases 7.4 Drug Screening and Development 7.5 Stem Cell Research 7.5.1 Stringent Regulations to Conduct Clinical Trials for New Stem Cell-Based Therapies on Human Subjects is Restraining the Growth of This Segment 7.6 Tissue Engineering & Regenerative Medicine 7.7 Other Applications 8 Cell Culture Market, By End User 8.1 Introduction 8.2 Pharmaceutical & Biotechnology Companies 8.2.1 Increasing Use of Single-Use Technologies is Driving the Growth of the Cell Culture Market for This Segment 8.3 Hospitals and Diagnostic Laboratories 8.3.1 Increasing Awareness for the Diagnosis of Various Diseases to Drive This Segment 8.4 Research Institutes 8.4.1 Increasing Government Funding for Research Projects and High Prevalence of Cancer to Drive the Cell Culture Market for Research Institutes 8.5 Cell Banks 8.5.1 Increasing Awareness of Preserving Stem Cells to Drive This Segment 9 Cell Culture Market, By Region 9.1 Introduction 9.2 North America 9.2.1 US 184.108.40.206 US to Dominate the North American Cell Culture Market 9.2.2 Canada 220.127.116.11 Advancement in the Field of Regenerative Medicine to Drive the Cell Culture Market in Canada 9.3 Europe 9.3.1 Germany 18.104.22.168 Increasing Investment By Various Key Players and Growing Funding From Government Organizations to Drive the Market 9.3.2 France 22.214.171.124 Support From Government and Private Investors to Drive the Market for Cell Culture in France 9.3.3 UK 126.96.36.199 Growth in the Life Science Industry to Drive the Market for Cell Culture in the UK 9.3.4 Italy 188.8.131.52 Increasing Number of Cell Biology Seminars and Conferences to Fuel the Adoption of Cell Culture Products 9.3.5 Spain 184.108.40.206 Increasing Funding From Private and Public Organizations to Aid Market Growth 9.3.6 RoE 9.4 Asia Pacific 9.4.1 Japan 220.127.116.11 Strategic Developments By Companies to Drive the Market for Cell Culture in Japan 9.4.2 China 18.104.22.168 Government Initiatives and Strategic Initiatives By Key Players to Strengthen the Biotechnology Industry in China 9.4.3 India 22.214.171.124 Growth Initiatives to Promote Life Science Industry to Drive the Market for Cell Culture in India 9.4.4 RoAPAC 9.5 Rest of the World (RoW) 10 Competitive Landscape 10.1 Overview 10.2 Market Share Analysis, 2019 10.3 Competitive Scenario 10.3.1 Partnerships, Agreements, and Collaborations (2016–2019) 10.3.2 Product Launches (2016–2019) 10.3.3 Expansions (2016–2019) 10.3.4 Acquisitions (2016–2019) 10.4 Competitive Leadership Mapping (2019) 10.4.1 Vendor Inclusion Criteria 10.4.2 Vanguards 10.4.3 Innovators 10.4.4 Dynamic Players 10.4.5 Emerging Players 11 Company Profiles (Business Overview, Products Offered, Recent Developments, FutureWise Insights)* 11.1 Becton, Dickinson and Company 11.2 Cellgenix 11.3 Corning 11.4 Danaher 11.5 Eppendorf 11.6 Fujifilm Irvine Scientific (Acquired By Fujifilm Corporation) 11.7 GE Healthcare (A Subsidiary of General Electric Company) 11.8 Hi-Media Laboratories 11.9 Invivogen 11.10 Lonza Group AG 11.11 Merck KGaA 11.12 Miltenyi Biotec 11.13 Promocell 11.14 Sartorius AG 11.15 Thermo Fisher Scientific 12 Research Finding and Conclusion 13 Appendix 13.1 Research Methodology 13.2 Research Data Source Inquire further details about this report at: [email protected] About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: [email protected] Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com
© Copyright 2021 Paperzz